Amerimmune LLC Maintains Intellectual Property on the COVID-19 Related Use of Caspase Inhibitors as a Result of Histogen Inc. Led Arbitration
January 18th, 2023:MCLEAN, Va.–(BUSINESS WIRE)–Amerimmune LLC is a translational medicine biotechnology firm focused on discovery and rapid development of novel therapies for diseases, including COVID-19.Amerimmune LLC had a discovery early in 2020, showing elevated caspase molecules in peripheral blood immune cells of COVID19 patients. Caspase molecules help build immunity to pathogens, but can also have […]
CIIC Welcomes All Infusion Associates Locations as 26th CIIC Member
December 14, 2022 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization comprised of select US Board-Certified Allergists and Immunologists in private practice, is proud to announce the addition of Infusion Associates (https://infusionassociates.com/) as the 26th member of our network. With over 90 healthcare professionals working in 13 locations, Infusion Associates has further […]
CIIC Welcomes 25th Member: Allergy Partners, PLLC
August 23, 2022 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization comprised of select Board-Certified Allergists and Immunologists in private practice throughout the USA, is proud to announce the addition of Allergy Partners, PLLC as its 25th member to the network. Allergy Partners is the nation’s largest single specialty practice with 136 […]
CIIC HAE Posters Presented at the American College of Allergy, Asthma & Immunology Conference
November, 2022, The American College of Allergy, Asthma & Immunology Conference: CIIC Member Dr. Bill Lumry did a great job presenting our first two Hereditary Angioedema (HAE) Posters, that have resulted from the CIIC – Trio Health partnership. Poster Title: Attack Location and Severity/Resolution In Patients With Hereditary Angioedema (HAE); Observations From Community Immunology Abstract […]
Trio Health (Trio) and the Consortium of Independent Immunology Clinics (CIIC) announce the launch of the Trio-CIIC HAE Registry
LOUISVILLE, CO, May 12, 2022 – Enabled by the FDA guidance on the expanded use of real-world data, Trio Health has partnered with the CIIC to create the ‘first of its kind’ HAE (Hereditary Angioedema) Patient Registry. Trio Health’s real-world data platform rapidly converts structured and unstructured EMR data, in real time, including physician notes, […]
Consortium of Independent Immunology Clinics (CIIC) Welcomes Two New Members
Irving, TX / October 21, 2021 – The Consortium of Independent Immunology Clinics (CIIC), a professional medical organization represented by a group of selected Board-Certified Allergists and Immunologists in private practice throughout the USA, is proud to announce the addition of two new members to its network. The addition of these providers and their clinic […]
Introducing the Creation of a Dynamic Rare Disease Patient Registry Platform
IRVING, TX, September 21, 2021 – Trio Health (Trio), in partnership with the Consortium of Independent Immunology Clinics (CIIC), has launched the creation of a dynamic rare disease patient registry platform to transform drug development for allergy, asthma, and immunology patients. This technology-driven and real-world data-based partnership will unite the power of the […]
Histogen and Amerimmune Report Publication on Emricasan in COVID-19
Histogen Inc. and its partner, Amerimmune, LLC, recently reported the publication of the potential utility of Emricasan in COVID-19 in Allergy, the official Journal of the European Academy of Allergy and Clinical Immunology. Amerimmune, in collaboration with Dr. Raavi Gupta from SUNY Downstate Medical Center and Dr. Lishomva Ndhlovu from Weill Cornell Medicine, demonstrated the […]
Histogen and Amerimmune Announce First Patient Dosed in Phase 1 Study of Emricasan in Symptomatic COVID-19 Patients
Yesterday, Histogen and Amerimmune, a research center and immunology laboratory owned by CIIC Member Dr. Oral Alpan, announced dosing the first patient in a Phase 1 study of Emricasan in mild symptomatic -COVID-19 patients to assess safety, tolerability, and preliminary efficacy. SUNY Downstate Medical Center in Brooklyn, New York, has been selected as the single […]
Clinical Cytometry
Today, the Consortium of Independent Immunology Clinics (CIIC) announces the publication of Validation of inducible basophil biomarkers: Time, temperature and transportation by Wiley Periodicals LLC on behalf of The Official Journal of the International Clinical Cytometry Society.